Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2025

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2025

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 516 117 82% 6% 399 81% 7%
I 4:i:- 358 12 67% 8% 346 53% 12%
London 123 6 50% 0% 117 49% 2%
Rissen 114 6 0% 0% 108 46% 1%
Typhimurium 92 4 50% 0% 88 89% 13%
Goldcoast 60 4 0% 0% 56 30% 9%
Derby 58 4 75% 0% 54 65% 0%
Typhi 11 11 91% 27% 0 - -
Others 316 22 55% 18% 294 44% 18%


Remarks:

Multiple strains may have been received from the same patient.